Inhibition of murine prostate tumor growth and activation of immmunoregulatory cells with recombinant canarypox viruses

Journal of the National Cancer Institute

Volumn 93, Issue 13, 2001, Pages 998-1007

  Griffith, Thomas S ^a   Kawakita, Mutsushi ^b   Tian, Jun ^a   Ritchey, Julie ^a,c   Tartaglia, James ^a,d   Sehgal, Inder ^a,e   Thompson, Timothy C ^a,e   Zhao, Weicheng ^a   Ratliff, Timothy L ^a  

^a UNIVERSITY OF IOWA   (United States)

^b KYOTO UNIVERSITY   (Japan)

^c WASHINGTON UNIVERSITY   (United States)

^d Aventis Pasteur   (Canada)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 2; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANARYPOX VIRUS; CANCER CELL; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CANCER SURVIVAL; CELL ACTIVATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG DELIVERY SYSTEM; GENETIC RECOMBINATION; IMMUNIZATION; IMMUNOGENICITY; IMMUNOMODULATION; IMMUNOREGULATION; MALE; MONITORING; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROSTATE TUMOR; STATISTICAL ANALYSIS; T LYMPHOCYTE; TUMOR CELL; TUMOR GROWTH; TUMOR IMMUNITY; VIRUS; VIRUS RECOMBINANT;

EID: 0035806491     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/93.13.998     Document Type: Article

References (43)

1. Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response
2. Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extracts
3. Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations
4. Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccina-CEA vaccine
5. A reassessment of the role of B7-1 expression in tumor rejection
6. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity
7. In vivo gene therapy of a murine pancreas tumor with recombinant vaccinia virus encoding human interleukin-1 beta
8. Recombinant vaccinia interleukin-2-infected tumor cell vaccines in immunotherapy of murine colon adenocarcinoma
9. High cytokine production and effective antitumor activity of a recombinant vaccinia virus encoding murine interleukin 12
10. Antimetastatic vaccination of tumor-bearing mice with two types of IFN-γ gene-inserted tumor cells
11. The role of IL-2 secreted from genetically modified tumor cells in the establishment of antitumor immunity
12. Vaccinia virus: A tool for research and vaccine development
13. Novel poxvirus strains as research tools and vaccine vectors
14. Efficacy studies on a canarypox-rabies recombinant virus
15. Immunisation with canarypox virus expressing rabies glycoprotein
16. Nonreplicating viral vectors as potential vaccines: Recombinant canarypox virus expressing measles virus fusion (F) and hemagglutinin (HA) glycoproteins
17. A prime-boost approach to HIV preventive vaccine using a recombinant canarypox virus expressing glycoprotein 160 (MN) followed by a recombinant glycoprotein 160 (MN/LAI)
18. Effect of canarypox virus (ALVAC)-mediated cytokine expression on murine prostate tumor growth
19. Evidence implicating L3T4 in class II MHC antigen reactivity, monoclonal antibody GK1.5 (anti-L3T4a) blocks class II MHC antigen-specific proliferation, release of lymphokines, and binding by cloned murine helper T lymphocyte lines
20. IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement
21. Establishment of monoclonal anti-Nk-1.1 antibody
22. + T helper 1 effectors
23. Protection of cats against feline leukemia virus by vaccination with a canarypox virus recombinant, ALVAC-FL
24. Induction of cytotoxic T lymphocytes by recombinant canarypox (ALVAC) and attenuated vaccinia (NYVAC) viruses expressing the HIV-1 envelope glycoprotein
25. Immunotherapeutic elimination of syngeneic tumors in vivo by cytotoxic T lymphocytes generated in vitro from lymphocytes from the draining lymph nodes of tumor-bearing mice
26. Suppressor T cells: Some answers but more questions
27. Revisiting and revising suppressor T cells
28. The role of antigen-specific T cell factors in the immune response
29. The biochemistry of antigen-specific T-cell factors
30. T cell-derived antigen binding molecules (TABM): Molecular and functional properties
31. The immune response and the eye. TCR α-chain related molecules regulate the systemic immunity to antigen presented in the eye
32. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production
33. + T cells: A common basis between tumor immunity and autoimmunity
34. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance
35. + regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells
36. Cancer statistics, 1999
37. NYVAC: A highly attenuated strain of vaccinia virus
38. Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule
39. Safety and immunogenicity of NYVAC-JEV and ALVAC-JEV attenuated recombinant Japanese encephalitis virus--poxvirus vaccines in vaccinia-nonimmune and vaccinia-immune humans
40. Cytokine profiles in seronegative volunteers immunized with a recombinant canarypox and gp120 prime-boost HIV-1 vaccine
41. Complications of smallpox vaccination, 1968
42. Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector
43. Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro: Inhibition by isoantibody and by drugs